# Prospective Randomised Study for Use of CHG Dressing at Entry Site of EVD's to Reduce EVD-associated Infections

> **NCT02078830** · NA · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 57 (actual)

## Conditions studied

- Wound Contamination

## Interventions

- **DEVICE:** 3M™ Tegaderm™ CHG I.V. Securement Dressing
- **DEVICE:** Placebo Comparator: 3M™ Tegaderm™ I.V. Advanced Dressing

## Key facts

- **NCT ID:** NCT02078830
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2016-03
- **Final completion:** 2017-03
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2017-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02078830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02078830, "Prospective Randomised Study for Use of CHG Dressing at Entry Site of EVD's to Reduce EVD-associated Infections". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02078830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*